Infection par le virus de l'hépatite C et réponse immunitaire :application au diagnostic et à la vaccination

Virologie

Volumn 1, Issue 3, 1997, Pages 217-228

  Fournillier Jacob, A ^a   Girard, M ^a   Wychowski, C ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Anti; Diagnostic; HCV antibodies; Hepatitis C virus; Vaccine

Indexed keywords

EID: 2742613461     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 1989 ; 244 :359-62.
2. Hijikata M, Mizushima H, Tanji Y, et al. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis-C virus. Proc Natl Acad Sci USA 1993 ; 90 :10773-7.
3. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993 ; 67 :1385-95.
4. Negro F, Pacchioni D, Mondardini A, Bussolati G, Bonino F. In situ hybridization in viral hepatitis. Liver 1992 ; 12 :217-26.
5. Krawczynski K, Beach MJ, Bradley DW, et al. Hepatitis-C virus antigen in hepatocytes - immunomorphologic detection and identification. Gastroenterology 1992 ; 103 :622-9.
6. Lerat H, Berby F, Trabaud MA, Vidalin O, Major M, Trépo C, Inchauspé G. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Investig 1996 ; 97 :845-51.
7. Nakajima N, Hijikata M, Yoshikura H, Shimizu YK. Characterization of long-term cultures of hepatitis C virus. J Virol 1996 ; 70 :3325-9.
8. Okamoto H, Kurai K, Okada SI, et al. Full-length sequence of a hepatitis-C virus genome having poor homology to reported isolates - Comparative study of four distinct genotypes. Virology 1992 ; 188 :331-41.
9. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis-C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993 ; 74 :2391-9.
10. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994 ; 68 :1494-500.
11. Farci P, Alter HJ, Wong DC, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 1994 ; 91 :7792-6.
12. Franco A, Barnaba V, Natali P, Balsano C, Musca A, Balsano F. Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology 1988 ; 8 :449-54.
13. Hoffman RM, Diepolder HM, Zachoval R, et al. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 1995 ; 21 :632-8.
14. Diepolder HM, Zachoval R, Hoffman RM, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995 ; 346 :1006-7.
15. Ferrari C, Valli A, Galati L, et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994 ; 19 :286-95.
16. Minutello MA, Pileri P, Unutmaaz D, et al. Compartmentalization of T lymphocytes to the site of disease :intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993 ; 178 :17-25.
17. Imawari M, Nomura M, Kaieda T, et al. Establishment of a human T-cell clone cytotoxic for both autologous and allogenic hepatocytes from chronic hepatitis patients with type non-A, non-B virus. Proc Natl Acad Sci USA 1989 ; 86 :2883-7.
18. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD Intrahepatic cytotoxic lymphocytes-T specific for hepatitis-C virus in persons with chronic hepatitis. J Immunol 1992 ; 149 :3339-44.
19. Erickson AL, Houghton M, Choo QL, Weiner AJ, Ralston R, Muchmore E, Walker CM. Hepatitis-C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis-C. J Immunol 1993 ; 151 :4189-99.
20. Cerny A, McHutchinson JG, Pasquinelli C, et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Investig 1995 ; 95 :521-30.
21. Kita H, Moriyama T, Kaneko T, et al. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology, 1993 ; 18 :1039-44.
22. Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989 ; 244 :362-4
23. Katayama T, Mazda T, Kikuchi S, et al. Improved serodiagnosis of non-A, non-B hepatitis by an assay detecting antibody to hepatitis C virus core antigen. Hepatology 1992 ; 15 :391-4.
24. Hino K. Diagnosis of hepatitis C. Intervirology 1994 ; 37 :77-86.
25. Inoue Y, Suzuki R, Matsuura Y, et al. Expression of the amino-terminal half of the NS1 region of the hepatitis C virus genome and detection of an antibody to the expressed protein in patients with liver diseases. J Gen Virol 1992 ; 73 :2151-4.
26. Lesniewski R, Okasinki G, Carrick R, et al. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein:a new marker of HCV infection closely associated with viremia. J Med Virol 1995 ; 45 :415-22.
27. Fourmilier-Jacob A, Lunel F, Cahour A, et al. Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C. J Med Virol 1997 (in press).
28. Saracco G, Abate ML, Baldi M, et al. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis. Liver 1994 ; 14 :65-70.
29. Maertens G, Ducatteeuw A, Barlet V, et al. Decrease of anti-E1 antibody levels during monitoring of IFN-α therapy correlates with long-term, sustained response to treatment. 2nd International Meeting on Hepatitis C and Related Viruses, San Diego 1996 ; p 265, abstract.
30. Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical backgrounds of the patients having different types of hepatitis-C virus genomes. J Hepatol 1992 ; 14 :35-40.
31. Prince AM, Brotman B, Huima T, Pascual D, Jaffery M, Inchauspe G. Immunity in hepatitis-C infection. J Infect Dis 1992 ; 165 :438-43
32. Farci P, Alter HJ, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis-C virus. Science 1992 ; 258 :135-40.
33. Choo QL, Kuo G, Ralston R. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 1994 ; 91 :1294-8.
34. Taniguchi S, Okamoto H, Sakamoto M, et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis-C virus E2/NS1 protein - Implication for an escape from antibody. Virology 1993 ; 195 :297-301.
35. Cahour A. Les perspectives d'un vaccin contre l'hépatite C :quelle stratégie adopter ? médecine/sciences 1995 ; 11 :81-91.
36. Ulmer JB, Donnelly JJ, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993 ; 259 :1745-9.
37. Wang B, Ugen KE, Srikantan V, et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993 ; 90 :4156-60.
38. Major ME, Vivitski L, Mink MA, Schleef M, Whalen RG, Trépo C, Inchauspé G. DNA-based immunisation with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol 1995 ; 69 :5798-809.
39. Rosa D, Campagnoli S, Moretto C, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus :cytofluorimetric assessement of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 1996 ; 93 :1759-63.